Cargando…
Fluorescence Lifetime Nanoscopy of Liposomal Irinotecan Onivyde: From Manufacturing to Intracellular Processing
[Image: see text] Onivyde was approved by the Food and Drug Administration (FDA) in 2015 for the treatment of solid tumors, including metastatic pancreatic cancer. It is designed to encapsulate irinotecan at high concentration, increase its blood-circulation lifetime, and deliver it to cells where i...
Autores principales: | Bernardi, Mario, Signore, Giovanni, Moscardini, Aldo, Pugliese, Licia Anna, Pesce, Luca, Beltram, Fabio, Cardarelli, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583229/ https://www.ncbi.nlm.nih.gov/pubmed/37699572 http://dx.doi.org/10.1021/acsabm.3c00478 |
Ejemplares similares
-
Liposomal irinotecan (Onivyde): Exemplifying the benefits of nanotherapeutic drugs
por: Milano, Gérard, et al.
Publicado: (2022) -
Onivyde for the therapy of multiple solid tumors
por: Zhang, Haijun
Publicado: (2016) -
Spatiotemporal Fluctuation Analysis: A Powerful Tool for the Future Nanoscopy of Molecular Processes
por: Di Rienzo, Carmine, et al.
Publicado: (2016) -
Quantitative determination of fluorescence labeling implemented in cell cultures
por: Schirripa Spagnolo, Chiara, et al.
Publicado: (2023) -
Infrared nanoscopy and tomography of intracellular structures
por: Kanevche, Katerina, et al.
Publicado: (2021)